Synta Pharmaceuticals(SNTA)

xlfrog2014-03-06 23:04

$Synta Pharmaceuticals(SNTA)$ CEO学物理的。多年来也没有搞定，board忍够了，开掉他。换了一个以前Incyte的CEO来board，难道他会是下任CEO？查看全文

Tanthius2014-03-06 06:00

LIST1，$Synta Pharmaceuticals(SNTA)$ ,$XG TECHNOLOGY INC(XGTI)$ ,$航美传媒(AMCN)$ ,$明阳风电(MY)$ ,$九洲大药房(CJJD)$ ,$ZBB ENERGY CORPORATION(ZBB)$ ,$Peregrine Pharmaceuticals(PPHM)$查看全文

xlfrog2014-03-04 07:08

$Synta Pharmaceuticals(SNTA)$ CEO辞职（实际被解职），立即生效！公司不给解释！这可不是好消息。等这baby到$5以下吧查看全文

xlfrog2014-02-28 22:48

$Synta Pharmaceuticals(SNTA)$ HSP90抑制剂有较多竞争对手，但目前只有SNTA的进入三期，而且没有眼睛的负作用（非常重要）。现在唯一可以期盼的东西就是三期结果。短期股价震荡（$5-7）都是正常的查看全文

xlfrog2014-02-27 01:21

$Synta Pharmaceuticals(SNTA)$ 仔细看了小鼠上人肿瘤模型的结果，还是很有意思的查看全文

xlfrog2014-02-24 23:13

$Synta Pharmaceuticals(SNTA)$ 原来是临床前的实验结果显示HDC偶联的化疗药物抗肿瘤有活性。离上临床太遥远了。而且与Seattle Genetics的ADC相比没有太多优势。还是等HSP90的三期结果吧查看全文

xlfrog2014-02-21 20:56

$Synta Pharmaceuticals(SNTA)$ 如果能重复二期结果，一定会飞起来。现在到三期接盲还有太长时间，来回震荡。。。查看全文

xlfrog2014-02-14 23:56

$Synta Pharmaceuticals(SNTA)$ 多空博弈。squeeze之后，看了又有新的short加入查看全文

金刚小黄人2014-02-11 03:39

$Synta Pharmaceuticals(SNTA)$ 查看全文

xlfrog2014-02-11 02:28

$Synta Pharmaceuticals(SNTA)$ short squeeze！查看全文

$Synta Pharmaceuticals(SNTA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-07 AccNo: 0001104659-18-049982 Size: 3 MB 网页链接

$Synta Pharmaceuticals(SNTA)$ S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers Filed: 2018-06-05 AccNo: 0001047469-18-004269 Size: 597 KB 网页链接

$Synta Pharmaceuticals(SNTA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-04-27 AccNo: 0001104659-18-027846 Size: 128 KB 网页链接

$Synta Pharmaceuticals(SNTA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-27 AccNo: 0001140361-18-020147 Size: 551 KB 网页链接

$Synta Pharmaceuticals(SNTA)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-27 AccNo: 0001140361-18-020146 Size: 4 MB 网页链接

$Synta Pharmaceuticals(SNTA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-27 AccNo: 0001140361-18-020147 Size: 551 KB 网页链接

$Synta Pharmaceuticals(SNTA)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-27 AccNo: 0001140361-18-020146 Size: 4 MB 网页链接

$Synta Pharmaceuticals(SNTA)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-13 AccNo: 0001047469-18-001557 Size: 5 MB 网页链接

$Synta Pharmaceuticals(SNTA)$ 8-K - Current report Filed: 2017-12-21 AccNo: 0001104659-17-074616 Size: 287 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$Synta Pharmaceuticals(SNTA)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-12-18 AccNo: 0001047469-17-007712 Size: 1 MB 网页链接